Evolution News and Research RSS Feed - Evolution News and Research

Rewriting the family history of Ebola

Rewriting the family history of Ebola

The research shows that filoviruses — a family to which Ebola and its similarly lethal relative, Marburg, belong — are at least 16-23 million years old. [More]
WHO holds meeting to discuss on how to fast track testing, deployment of Ebola vaccines

WHO holds meeting to discuss on how to fast track testing, deployment of Ebola vaccines

WHO convened a meeting with high-ranking government representatives from Ebola-affected countries and development partners, civil society, regulatory agencies, vaccine manufacturers and funding agencies yesterday to discuss and agree on how to fast track testing and deployment of vaccines in sufficient numbers to impact the Ebola epidemic. [More]
Study on blind cave fish could reveal mechanisms behind eye disease, other human ailments

Study on blind cave fish could reveal mechanisms behind eye disease, other human ailments

Blind cave fish may not be the first thing that comes to mind when it comes to understanding human sight, but recent research indicates they may have quite a bit to teach us about the causes of many human ailments, including those that result in loss of sight. [More]
Study outlines how unique pathogen uses the release of ROS as signal to infect healthy people

Study outlines how unique pathogen uses the release of ROS as signal to infect healthy people

New research into a rare pathogen has shown how a unique evolutionary trait allows it to infect even the healthiest of hosts through a smart solution to the body's immune response against it. [More]
IU Bloomington biologists to receive funding from NSF’s Dimensions of Biodiversity Program

IU Bloomington biologists to receive funding from NSF’s Dimensions of Biodiversity Program

Indiana University Bloomington biologists who specialize in the ecology and evolution of microbes have been named one of 12 teams in the nation to receive funding from the National Science Foundation's Dimensions of Biodiversity Program. [More]
Highland completes US$25 million offering of Class A Common Shares

Highland completes US$25 million offering of Class A Common Shares

Highland Therapeutics Inc., a pharmaceutical company, today announced it has completed a US$25 million offering of Class A Common Shares. The financing was led by a private equity partner that is committed to Highland's long-term success. [More]
Addressing the evolution of diversity in medical education

Addressing the evolution of diversity in medical education

A perspective piece in this week's issue of the New England Journal of Medicine from a student at the University of Pennsylvania's Perelman School of Medicine addresses the evolution of diversity in medical education. [More]
Quick, forceful implementation of control interventions necessary to control Ebola outbreaks

Quick, forceful implementation of control interventions necessary to control Ebola outbreaks

New Ebola research demonstrates that quick and forceful implementation of control interventions are necessary to control outbreaks and avoid far worse scenarios. [More]
NCCN publishes 20th annual editions of NCCN Guidelines for Colon and Rectal Cancers

NCCN publishes 20th annual editions of NCCN Guidelines for Colon and Rectal Cancers

The National Comprehensive Cancer Network has published the 20th annual editions of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon and Rectal Cancers, two of the eight original NCCN Guidelines published in November 1996. [More]
New research reveals innovative way to classify severity of stroke

New research reveals innovative way to classify severity of stroke

New research conducted at the Florida State University-based National High Magnetic Field Laboratory has revealed a new, innovative way to classify the severity of a stroke, aid in diagnosis and evaluate potential treatments. [More]
Social status can impact health, happiness even among egalitarian forager-farmers

Social status can impact health, happiness even among egalitarian forager-farmers

In western society, where keeping up with the Joneses — or, better yet, surpassing them — is expected and even encouraged, status matters. So important is it that for many people, physical and emotional wellbeing are directly connected to their place in the social hierarchy. [More]
Two UCSD professors of psychiatry honored for schizophrenia research

Two UCSD professors of psychiatry honored for schizophrenia research

Two professors of psychiatry at University of California, San Diego School of Medicine have been honored by the New York City-based Brain & Behavior Research Foundation for their work studying the genetics, dysfunction and treatment of schizophrenia, a chronic and severe brain disorder affecting roughly 1 percent of the general population or approximately 3 million people. [More]
GeneSolve to license its health optimization system to highly qualified doctors

GeneSolve to license its health optimization system to highly qualified doctors

GeneSolve announced today that it will begin licensing its proprietary health optimization system to a network of highly qualified doctors nationwide. [More]

Global Village Consulting renamed as Gevity Consulting

Global Village Consulting (Canada) announced today, effective immediately, it will operate under the name Gevity Consulting Inc. At the same time, the company unveiled a new logo and visual brand identity. [More]
Avidity NanoMedicines closes $6M convertible note financing, expands investor syndicate

Avidity NanoMedicines closes $6M convertible note financing, expands investor syndicate

Avidity NanoMedicines today announced that it has expanded its investor syndicate through the closing of a $6 million convertible note financing co-led by Fidelity Biosciences and TPG Biotech. [More]
FDA grants orphan drug designation for neuroblastoma vaccine

FDA grants orphan drug designation for neuroblastoma vaccine

The U.S. Food and Drug Administration granted orphan drug designation for a neuroblastoma vaccine from MabVax Therapeutics, providing development incentive with market exclusivity of the novel treatment for children with this deadly childhood cancer. [More]

Reuters, ProPublica and The Huffington Post bag Barlett & Steele Awards

ProPublica, Reuters and The Huffington Post won gold, silver and bronze awards, respectively, in the eighth annual Barlett & Steele Awards for Investigative Business Journalism, the Donald W. Reynolds National Center for Business Journalism announced today. [More]
New study shows rapid evolution of cerebellum in humans, apes

New study shows rapid evolution of cerebellum in humans, apes

A new study published in the Cell Press journal Current Biology on October 2 could rewrite the story of ape and human brain evolution. While the neocortex of the brain has been called "the crowning achievement of evolution and the biological substrate of human mental prowess," newly reported evolutionary rate comparisons show that the cerebellum expanded up to six times faster than anticipated throughout the evolution of apes, including humans. [More]
Humalog 200 units/ml KwikPen insulin gets marketing approval in EU for treatment of diabetes

Humalog 200 units/ml KwikPen insulin gets marketing approval in EU for treatment of diabetes

Eli Lilly and Company today announced that the European Commission has granted marketing authorisation for Humalog 200 units/ml KwikPen (insulin lispro 200 units/ml) for the treatment of diabetes in adults. [More]
ProMedica and Harbor team up to address growing community need for mental health services

ProMedica and Harbor team up to address growing community need for mental health services

Today ProMedica and Harbor announced plans to form a joint operating company (JOC) to address a growing community need for mental health services in northwest Ohio and southeast Michigan. [More]